Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision making.
about
A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancerStructuring and validating a cost-effectiveness model of primary asthma prevention amongst children.Cost-utility analyses of drug therapies in breast cancer: a systematic review.Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010.The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance.Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).
P2860
Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision making.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Methodological issues in evalu ...... elling to aid decision making.
@en
Methodological issues in evalu ...... elling to aid decision making.
@nl
type
label
Methodological issues in evalu ...... elling to aid decision making.
@en
Methodological issues in evalu ...... elling to aid decision making.
@nl
prefLabel
Methodological issues in evalu ...... elling to aid decision making.
@en
Methodological issues in evalu ...... elling to aid decision making.
@nl
P1433
P1476
Methodological issues in evalu ...... elling to aid decision making.
@en
P2093
Lieven Annemans
P2860
P304
P356
10.2165/00019053-200826050-00005
P577
2008-01-01T00:00:00Z
P6179
1031326421